Atish D. Choudhury, MD, PhD, discusses findings from the A-DREAM / Alliance A032101 trial evaluating treatment interruption following favorable response to combination ADT and ARPI therapy in mHSPC.
Atish D. Choudhury, MD, PhD
Advertisement
Articles by Atish D. Choudhury, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA grants tentative approval to generic enzalutamide tablets
2
ARASEC: Clinical Implications and the Role of Multidisciplinary Care
3
2026 AUA/SUO Advanced Prostate Cancer Guideline: Key updates and clinical FAQs
4
Fred Saad, MD, highlights PSA end points from the phase 3 PSMAddition trial
5